Navigation Links
Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81.
Date:10/25/2011

4%4%1%9%   Total Customer Sales12%5%1%6%Business Unit Sales(in millions)First
Quarter 2010Second
Quarter 2010Third
Quarter 2010Fourth
Quarter 2010Total
2010   Research Essentials$
2$
7$
5$$
434   Research Specialties217207207214845   Research Biotech91838487345   Research Chemicals4203973964111,624   SAFC152157167171647   Total Customer Sales$
572$
554$
563$
582$
2,271First
Quarter 2011Second
Quarter 2011Third
Quarter 2011Fourth
Quarter 2011Total
2011   Research Essentials$
20$
24$
21$
-$
365   Research Specialties236236231-703   Research Biotech969494-284   Research Chemicals452454446-1,352   SAFC180183180-543   Total Customer Sales$
32$
37$
26$
-$
,895SIGMA-ALDRICH CORPORATIONSupplemental Financial Information - (Unaudited)Reconciliation of Reported Net Income to Adjusted Net IncomeNet IncomeDiluted Earnings (in millions)Per ShareThree Months EndedThree Months EndedSeptember 30,September 30,2011201020112010Reported net income$
7$
93$
.95$
.76Restructuring costs

130.010.02Impairment costs

-7-0.05Adjusted net income

$
8$
3$
.96$
.83Net IncomeDiluted Earnings (in millions)Per ShareNine Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Reported net income$
349$
290$
2.84$
2.36Restructuring costs

590.040.07Impairment costs

-7-0.05Adjusted net income

$
354$
306$
2.88$
2.48Income Statement RatiosThree Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Gross profit

53.2%52.9%52.8%53.0%S,G&A expenses

24.3%24.7%23.8%24.0%Operating income

25.6%23.4%25.7%24.9%Pretax income

25.2%23.3%25.4%24.6%Net income

18.7%16.5%18.4%17.2%Effective tax rate

25.9%29.0%27.4%30.3%Reconciliation of Reported Operating Income Margin to Adj
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
3. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
6. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
7. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
8. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
9. Sigma-Aldrich to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010
10. Sigma-Aldrich(R) Licenses RAFT Polymerization Technology From CSIRO(R)
11. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Cogentix Medical, Inc. (NASDAQ: CGNT ), a ... release financial results for the first quarter of fiscal year ... on Monday, August 10, 2015. The Company ... results on Monday, August 10, 2015 at 4:30 p.m. Eastern ... and Chief Executive Officer, and Brett Reynolds , Chief ...
(Date:7/29/2015)... N.Y., July 29, 2015  Henry Schein, Inc. ... of health care products and services to office-based ... record second quarter financial results. Net ... were $2.6 billion, an increase of 0.5% compared ... of 7.5% growth in local currencies and a ...
(Date:7/29/2015)... SUNNYVALE, Calif. , July 29, 2015 /PRNewswire/ ... international availability of an update to Xpert® Carba-R, ... genes, OXA-181 and OXA-232.  The on-demand, molecular test ... prevalent mechanisms of carbapenem resistance, namely KPC, NDM, ... commonly referred to as CROs or Superbugs, are ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4
... (NASDAQ: TECH ) financial results for the quarter ... First quarter earnings were $27.5 million or $.74 per diluted ... million or $.81 per diluted share after adjustment for intangible ... that was written-up to fair value as part of acquisitions ...
... 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. ... leading China-based advanced in-vitro diagnostic ("IVD") company, today ... of its American Depositary Shares ("ADSs") from two ... with the issuance of the Company,s convertible notes ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Company's Convertible Notes in August 2008 2
(Date:7/29/2015)... ... , ... The New Foundation AZ recently started a massive renovation ... the 501(c) organization nearly $1 million, will both update the facilities’ design and fixtures ... down to the studs,” said Geraldine Leary, the New Foundation AZ chief executive officer. ...
(Date:7/29/2015)... ... ... The Woodlands and Spring Fit Body Boot Camps have implemented an engaging ... month. The new system will track each time a client uses social media to ... the boot camps will donate 20 cents to a selected charity. , Fit Body ...
(Date:7/29/2015)... Burnsville MN (PRWEB) , ... July 29, 2015 ... ... manufacturer, announces that it has entered into a partnership with 247Ergo, an ergonomics ... physical health and wellness. Ergonomics projects that the companies undertake could improve worker ...
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, ... the home of Zerorez Indianapolis, which plans to expand across the state. , Ray ... our second full year in business and we should double our first year’s revenue. ...
(Date:7/29/2015)... Sarasota, FL (PRWEB) , ... July 29, 2015 ... ... SkinSmart Dermatology, is the first dermatologist in Sarasota to be chosen by the ... treatments. , “Kybella offers the first injectable, non-invasive way to treat and eliminate ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... for years that psychological trauma that results in ... how a person responds to stress. Now, Cornell ... ones, life-threatening accidents and other such traumas may ... doesn,t develop a clinical disorder., "The findings suggest ...
... The soaring obesity rates across the globe have been ... the 21st century. A top university researcher argues that ... this obesity epidemic. , In an article published in ... examines the vital role physicians play in managing and ...
... often assumed to be the top truants in American medicine, ... and less treatable. However, a new study by Dartmouth researchers ... slip through the cracksat least when it comes to colorectal ... two types of cancer, the study found that urban patients ...
... DALLAS, Nov. 20 Crdentia Corp. (OTC Bulletin,Board: ... the,promotion of Ms. Penny Kirsch to Vice President ... Human Resources Manager,for Crdentia and will continue to ... Kirsch will be responsible for all human resources ...
... RGEN ) announced today that the Company President and ... upcoming,healthcare conferences in New York, NY. -- Lazard Capital ... Wednesday, November 28, 2007 at 11:00 A.M. EST at the ... Avenue, New York, NY. -- BMO Capital Markets Focus ...
... CHICAGO, Nov. 20 Advanced Life Sciences,Holdings, Inc. ... will present at the,Lazard Capital Markets Fourth Annual ... audio. Advanced Life Sciences, management will,provide an overview ... http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO ) The Company,s presentation will ...
Cached Medicine News:Health News:Top researcher argues most physicians aren't prepared to deal with obesity epidemic 2Health News:Rural patients' colon and lung cancers diagnosed earlier, Dartmouth research says 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 3Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 2Health News:Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th 3Health News:Advanced Life Sciences to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2
... designed for LASIK surgery and other types ... corneal interface and/or stromal bed. Flattened tip ... helps elevate the flap edge. Multiple ports ... x 22mm) Formed 7mm from end. Two ...
... Unique product designed for LASIK ... surgery. Designed to irrigate the corneal ... provides easy insertion under the flap ... Multiple ports provide multi-directional irrigation. 25G ...
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 20G x 7.8in (.90 x 22mm)....
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
Medicine Products: